Trade Mark Journal No.2026/041 9 October 2026

WO0000001938957 (1,9,42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:5 August 2026
Date of designation in the UK: 5 August 2026
Image for mark 1938957_TIF CELLbricate

International priority date claimed: 2 March 2026 (European Union Intellectual Property Office (EUIPO)) (019323586)
Class 1
Chemical and biochemical preparations for use in research and laboratories, in particular reagents for pharmacological research; chemical reagents for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for biological analysis of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; kits containing chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits containing chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; chemical reagents for chromatographic immobilization, purification or isolation of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for the activation or stimulation of cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for genetically modifying body cells, stem cells and cells of the immune system of mammals including human cells, T-cells, B-cells, natural killer cells and monocytes; chemical reagents for transferring genes into body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.
Class 9
Laboratory apparatus for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for biological analysis of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; scientific apparatus for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; laboratory apparatus for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, the apparatus including a body fluid collection unit, a cell processing unit and a unit for releasing the manufactured cellular therapy unit; scientific apparatus for the washing of cells obtained from a biological sample, in particular for washing of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; laboratory apparatus for the manufacture of cellular therapy products including apparatus for the chromatographic immobilization, purification or isolations of cells and apparatus for the transfer of genes into cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; laboratory apparatus for the manufacture of cellular therapy products including apparatus for the chromatographic immobilization, purification or isolations of cells, apparatus of activation or stimulation of cells, and apparatus for the transfer of genes into cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.
Class 42
Scientific services and research relating thereto in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, in particular cellular therapy products, including body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, diagnostic preparations and biomarker reagents and/or diagnostic apparatus.

TQ Therapeutics GmbH

Representative: SCHIWECK WEINZIERL KOCH PATENTANWÄLTE PARTNERSCHAFT MBB, Ganghoferstrasse 68b, 80339 München, GERMANY